newsfilter
← Latest News
GlobeNewswire·

Surface Oncology to Participate in the Gilmartin Group Emerging Growth Company Showcase

CAMBRIDGE, Mass., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief e